Alcaftadine Patent Expiration
Alcaftadine is Used for temporarily relieving itchy eyes caused by allergens such as pollen, ragweed, grass, animal hair, and dander. It was first introduced by Abbvie Inc
Alcaftadine Patents
Given below is the list of patents protecting Alcaftadine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lastacaft | US8664215 | Ocular allergy treatments with alcaftadine | Dec 23, 2027 | Abbvie |
| Lastacaft | US10617695 | Ophthalmic compositions containing alcaftadine | Mar 19, 2027 | Abbvie |
| Lastacaft | US5468743 | Imidazo[2,1-b]benzazepine derivatives, compositions and method of use |
Nov 21, 2013
(Expired) | Abbvie |
Alcaftadine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List